SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-014324
Filing Date
2023-01-24
Accepted
2023-01-24 17:13:32
Documents
14
Period of Report
2023-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d456243d8k.htm   iXBRL 8-K 32624
2 EX-2.1 d456243dex21.htm EX-2.1 38219
3 EX-10.1 d456243dex101.htm EX-10.1 31273
  Complete submission text file 0001193125-23-014324.txt   251078

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20230124.xsd EX-101.SCH 2844
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20230124_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20230124_pre.xml EX-101.PRE 11703
8 EXTRACTED XBRL INSTANCE DOCUMENT d456243d8k_htm.xml XML 3513
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 23548985
SIC: 2834 Pharmaceutical Preparations